Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharma-Bio Serv (PBSV) Revenue (2016 - 2025)

Historic Revenue for Pharma-Bio Serv (PBSV) over the last 16 years, with Q4 2025 value amounting to $2.1 million.

  • Pharma-Bio Serv's Revenue fell 787.19% to $2.1 million in Q4 2025 from the same period last year, while for Oct 2025 it was $9.0 million, marking a year-over-year decrease of 534.41%. This contributed to the annual value of $9.0 million for FY2025, which is 534.41% down from last year.
  • Pharma-Bio Serv's Revenue amounted to $2.1 million in Q4 2025, which was down 787.19% from $2.0 million recorded in Q3 2025.
  • Over the past 5 years, Pharma-Bio Serv's Revenue peaked at $5.6 million during Q4 2021, and registered a low of $2.0 million during Q3 2025.
  • Its 5-year average for Revenue is $3.8 million, with a median of $4.4 million in 2021.
  • As far as peak fluctuations go, Pharma-Bio Serv's Revenue soared by 1182.62% in 2022, and later plummeted by 4789.52% in 2024.
  • Over the past 5 years, Pharma-Bio Serv's Revenue (Quarter) stood at $5.6 million in 2021, then fell by 17.13% to $4.6 million in 2022, then decreased by 22.42% to $3.6 million in 2023, then crashed by 35.15% to $2.3 million in 2024, then dropped by 7.87% to $2.1 million in 2025.
  • Its last three reported values are $2.1 million in Q4 2025, $2.0 million for Q3 2025, and $2.4 million during Q2 2025.